Physician profile
William H Pullen
NPI 1629009105
$1,676.93
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $851 · 2020: $187 · 2021: $230 · 2022: $409.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $448.67 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $433.05 | 2019 | |
| Kci USA, INC. | $208.89 | 2019-2022 | |
| Organogenesis INC. | $173.58 | 2019-2021 | |
| Aroa Biosurgery Incorporated | $97.97 | 2020 | |
| Allergan, INC. | $66.53 | 2019-2020 | |
| Melinta Therapeutics, LLC | $58.28 | 2021-2022 | |
| Hydrofera LLC | $48.32 | 2021 | |
| Bioventus LLC | $44.86 | 2022 | |
| Abbvie INC. | $43.97 | 2021-2022 | |
| Coloplast Corp | $25.22 | 2021 | |
| Medline Industries LP | $14.54 | 2020 | |
| Acera Surgical, INC. | $13.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Pullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.